There are limited supplies of preserved dexamethasone (Maxidex®)
0.1% eye drops in a multi-dose container until early August 2021 due to a
manufacturing issue. During this period stock
will only be available to order directly from Novartis and subject to order
limits.
Dexamethasone 0.1% preservative free and alternative
steroid eye drops remain available in single dose and multi-dose containers and collectively
can support an uplift in demand.
For patients with insufficient supplies until the resupply
date, clinicians should consider prescribing an alternative preparation as appropriate.
Patients who are on long term treatment should be fully
counselled if switched to alternative preparations, particularly preservative
free single dose preparations, due to the need to dispose of the unit dose
after use.
This alert contains further information and action for providers.
Please note that no response is required via the CAS website to this alert.